MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 150 filers reported holding MOMENTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,139,000 | +54.0% | 174,144 | -2.4% | 0.02% | +46.7% |
Q2 2020 | $5,935,000 | +76.5% | 178,389 | +44.3% | 0.02% | +50.0% |
Q1 2020 | $3,362,000 | +37.8% | 123,610 | 0.0% | 0.01% | +66.7% |
Q4 2019 | $2,439,000 | +57.7% | 123,610 | +3.5% | 0.01% | +50.0% |
Q3 2019 | $1,547,000 | +4.1% | 119,374 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,486,000 | -14.4% | 119,374 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,735,000 | +33.2% | 119,374 | +1.1% | 0.00% | 0.0% |
Q4 2018 | $1,303,000 | -55.4% | 118,062 | +6.2% | 0.00% | -42.9% |
Q3 2018 | $2,924,000 | +28.6% | 111,162 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $2,273,000 | +13.5% | 111,162 | +0.8% | 0.01% | +20.0% |
Q1 2018 | $2,003,000 | +30.1% | 110,334 | +0.0% | 0.01% | +25.0% |
Q4 2017 | $1,539,000 | -15.0% | 110,316 | +12.7% | 0.00% | -20.0% |
Q3 2017 | $1,811,000 | +14.2% | 97,875 | +4.3% | 0.01% | +25.0% |
Q2 2017 | $1,586,000 | +26.8% | 93,875 | +0.2% | 0.00% | +33.3% |
Q1 2017 | $1,251,000 | -11.3% | 93,675 | 0.0% | 0.00% | -25.0% |
Q4 2016 | $1,410,000 | +28.8% | 93,675 | 0.0% | 0.00% | +33.3% |
Q3 2016 | $1,095,000 | +8.2% | 93,675 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,012,000 | +17.3% | 93,675 | +0.3% | 0.00% | +50.0% |
Q1 2016 | $863,000 | -37.2% | 93,375 | +0.9% | 0.00% | -50.0% |
Q4 2015 | $1,374,000 | +4.4% | 92,575 | +15.5% | 0.00% | 0.0% |
Q3 2015 | $1,316,000 | -5.3% | 80,175 | +31.5% | 0.00% | 0.0% |
Q2 2015 | $1,390,000 | +65.5% | 60,952 | +10.3% | 0.00% | +100.0% |
Q1 2015 | $840,000 | -13.8% | 55,265 | -31.7% | 0.00% | +100.0% |
Q4 2014 | $974,000 | +130.3% | 80,930 | +117.2% | 0.00% | 0.0% |
Q3 2014 | $423,000 | -6.0% | 37,265 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $450,000 | +3.7% | 37,265 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $434,000 | -36.0% | 37,265 | -2.9% | 0.00% | -50.0% |
Q4 2013 | $678,000 | +17.1% | 38,365 | -4.7% | 0.00% | 0.0% |
Q3 2013 | $579,000 | -8.5% | 40,265 | -4.3% | 0.00% | 0.0% |
Q2 2013 | $633,000 | – | 42,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |